pipette
ESEspañol

Gfa, a new integron-borne fosfomycin resistance family

N. Kieffer, A. Prieto, L. Ortiz-Miravalles, A. Hipolito, E. Vergara, J. Borrero del Pino, A. Carvalho, J.-A. Escudero

PreprintReal-world use

In the authors' words

Fosfomycin is increasingly used to treat multidrug-resistant Gram-negative infections, yet resistance surveillance largely relies on homology-based detection of known fos genes. Here, we identify Gfa, a previously unrecognized integron-borne fosfomycin resistance determinant uncovered through functional screening of 129 integron gene cassettes. Gfa confers high-level fosfomycin resistance across Enterobacterales and Pseudomonas aeruginosa and is resistant to phosphonoformate inhibition. Structural modelling and mutagenesis reveal a conserved cysteine-rich, zinc-organized architecture essential for activity and distinct from canonical Fos enzymes. Crude-extract assays confirm glutathione-dependent fosfomycin inactivation under metal-chelating conditions. Distant Gfa homologs also conferred resistance, although activity was restricted to a subset of proteins tested. Together, these findings establish Gfa as a previously unrecognized fosfomycin resistance family and highlight the limitations of homology-based mining for discovering novel resistance determinants and predicting which family members are functional.

Main resultLimitation the authors admit

Appeared: Friday, October 9. bioRxiv. Preprint, not yet peer-reviewed.

DOI: 10.64898/2026.10.07.757220